HEADER OXIDOREDUCTASE 01-SEP-11 3TMZ TITLE CRYSTAL STRUCTURE OF P450 2B4(H226Y) IN COMPLEX WITH AMLODIPINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYTOCHROME P450 2B4; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CYPIIB4, CYTOCHROME P450 ISOZYME 2, CYTOCHROME P450 LM2, COMPND 5 CYTOCHROME P450 TYPE B0, CYTOCHROME P450 TYPE B1; COMPND 6 EC: 1.14.14.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ORYCTOLAGUS CUNICULUS; SOURCE 3 ORGANISM_COMMON: EUROPEAN RABBIT,JAPANESE WHITE RABBIT,DOMESTIC SOURCE 4 RABBIT,RABBITS; SOURCE 5 ORGANISM_TAXID: 9986; SOURCE 6 GENE: CYP2B4; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: TOPP3; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PKK KEYWDS P450, CYTOCHROME P450 2B4, MONOOXYGENASE, OXIDOREDUCTASE, MEMBRANE KEYWDS 2 PROTEIN, CYP 2B4 EXPDTA X-RAY DIFFRACTION AUTHOR M.B.SHAH,J.PASCUAL,C.D.STOUT,J.R.HALPERT REVDAT 3 13-SEP-23 3TMZ 1 REMARK SEQADV LINK REVDAT 2 03-OCT-12 3TMZ 1 JRNL REVDAT 1 12-SEP-12 3TMZ 0 JRNL AUTH M.B.SHAH,P.R.WILDERMAN,J.PASCUAL,Q.ZHANG,C.D.STOUT, JRNL AUTH 2 J.R.HALPERT JRNL TITL CONFORMATIONAL ADAPTATION OF HUMAN CYTOCHROME P450 2B6 AND JRNL TITL 2 RABBIT CYTOCHROME P450 2B4 REVEALED UPON BINDING MULTIPLE JRNL TITL 3 AMLODIPINE MOLECULES. JRNL REF BIOCHEMISTRY V. 51 7225 2012 JRNL REFN ISSN 0006-2960 JRNL PMID 22909231 JRNL DOI 10.1021/BI300894Z REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.93 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.4 REMARK 3 NUMBER OF REFLECTIONS : 33933 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.194 REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1786 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.25 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.31 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1650 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 65.00 REMARK 3 BIN R VALUE (WORKING SET) : 0.3490 REMARK 3 BIN FREE R VALUE SET COUNT : 92 REMARK 3 BIN FREE R VALUE : 0.3950 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3694 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 133 REMARK 3 SOLVENT ATOMS : 203 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.04000 REMARK 3 B22 (A**2) : -0.04000 REMARK 3 B33 (A**2) : 0.06000 REMARK 3 B12 (A**2) : -0.02000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.213 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.201 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.151 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.177 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.959 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.934 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3950 ; 0.023 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5366 ; 2.085 ; 2.041 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 460 ; 6.944 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 177 ;36.053 ;22.881 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 625 ;16.615 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 31 ;16.371 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 581 ; 0.194 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3014 ; 0.012 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2310 ; 1.170 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3746 ; 2.129 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1640 ; 3.066 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1620 ; 4.842 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3TMZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-SEP-11. REMARK 100 THE DEPOSITION ID IS D_1000067672. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-DEC-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOXDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36346 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.248 REMARK 200 RESOLUTION RANGE LOW (A) : 38.938 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 6.200 REMARK 200 R MERGE (I) : 0.04300 REMARK 200 R SYM (I) : 0.04300 REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.37 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.49800 REMARK 200 R SYM FOR SHELL (I) : 0.49800 REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3MVR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.06 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.52 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1M K/NA TARTARATE, 0.1 M TRIS, 0.2M REMARK 280 LI2SO4, PH 7, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 50.92433 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 101.84867 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 101.84867 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 50.92433 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 20 REMARK 465 ALA A 21 REMARK 465 LYS A 22 REMARK 465 LYS A 23 REMARK 465 THR A 24 REMARK 465 SER A 25 REMARK 465 SER A 26 REMARK 465 LYS A 27 REMARK 465 ARG A 48 REMARK 465 GLY A 136 REMARK 465 HIS A 493 REMARK 465 HIS A 494 REMARK 465 HIS A 495 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 49 CG CD CE NZ REMARK 470 ARG A 53 CZ NH1 NH2 REMARK 470 ARG A 57 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 73 NE CZ NH1 NH2 REMARK 470 LYS A 139 CG CD CE NZ REMARK 470 LYS A 326 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLN A 215 C VAL A 216 N 0.193 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 263 -174.49 -171.90 REMARK 500 HIS A 335 -72.32 -97.19 REMARK 500 SER A 430 -161.29 75.53 REMARK 500 VAL A 477 -9.59 -53.53 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 501 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 436 SG REMARK 620 2 HEM A 501 NA 96.6 REMARK 620 3 HEM A 501 NB 90.9 90.9 REMARK 620 4 HEM A 501 NC 93.4 170.0 90.1 REMARK 620 5 HEM A 501 ND 95.6 87.8 173.5 90.1 REMARK 620 6 06X A 503 NAD 165.1 73.4 78.5 97.1 95.0 REMARK 620 7 06X A 503 NAD 167.5 73.8 81.6 96.6 91.9 3.1 REMARK 620 N 1 2 3 4 5 6 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CM5 A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 06X A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 06X A 504 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2Q6N RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH 1-(4-CHLOROPHENYL)IMIDAZOLE REMARK 900 RELATED ID: 3KW4 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH TICLOPIDINE REMARK 900 RELATED ID: 2BDM RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH BIFONAZOLE REMARK 900 RELATED ID: 1SUO RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH 4-(4-CHLOROPHENYL)IMIDAZOLE REMARK 900 RELATED ID: 3ME6 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH CLOPIDOGREL REMARK 900 RELATED ID: 3MVR RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN A LIGAND FREE CLOSED CONFORMATION REMARK 900 RELATED ID: 3G5N RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE REMARK 900 (TRIPLE LIGAND OCCUPANCY) REMARK 900 RELATED ID: 3R1A RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH TERT-BUTYLPHENYLACETYLENE (CLOSED REMARK 900 CONFORMATION) REMARK 900 RELATED ID: 1PO5 RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN A LIGAND FREE OPEN CONFORMATION REMARK 900 RELATED ID: 3G93 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE REMARK 900 (SINGLE LIGAND OCCUPANCY) REMARK 900 RELATED ID: 3R1B RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH TERT-BUTYLPHENYLACETYLENE (OPEN REMARK 900 CONFORMATION) REMARK 999 REMARK 999 SEQUENCE REMARK 999 AUTHORS INDICATE THAT THERE IS AN ERROR IN THE SEQUENCE DATABASE REMARK 999 REFERENCE AT RESIDUE 221 DBREF 3TMZ A 20 491 UNP P00178 CP2B4_RABIT 1 491 SEQADV 3TMZ ALA A 21 UNP P00178 GLU 2 ENGINEERED MUTATION SEQADV 3TMZ A UNP P00178 PHE 3 DELETION SEQADV 3TMZ A UNP P00178 SER 4 DELETION SEQADV 3TMZ A UNP P00178 LEU 5 DELETION SEQADV 3TMZ A UNP P00178 LEU 6 DELETION SEQADV 3TMZ A UNP P00178 LEU 7 DELETION SEQADV 3TMZ A UNP P00178 LEU 8 DELETION SEQADV 3TMZ A UNP P00178 LEU 9 DELETION SEQADV 3TMZ A UNP P00178 ALA 10 DELETION SEQADV 3TMZ A UNP P00178 PHE 11 DELETION SEQADV 3TMZ A UNP P00178 LEU 12 DELETION SEQADV 3TMZ A UNP P00178 ALA 13 DELETION SEQADV 3TMZ A UNP P00178 GLY 14 DELETION SEQADV 3TMZ A UNP P00178 LEU 15 DELETION SEQADV 3TMZ A UNP P00178 LEU 16 DELETION SEQADV 3TMZ A UNP P00178 LEU 17 DELETION SEQADV 3TMZ A UNP P00178 LEU 18 DELETION SEQADV 3TMZ A UNP P00178 LEU 19 DELETION SEQADV 3TMZ A UNP P00178 PHE 20 DELETION SEQADV 3TMZ A UNP P00178 ARG 21 DELETION SEQADV 3TMZ LYS A 22 UNP P00178 GLY 22 ENGINEERED MUTATION SEQADV 3TMZ LYS A 23 UNP P00178 HIS 23 ENGINEERED MUTATION SEQADV 3TMZ THR A 24 UNP P00178 PRO 24 ENGINEERED MUTATION SEQADV 3TMZ SER A 25 UNP P00178 LYS 25 ENGINEERED MUTATION SEQADV 3TMZ SER A 26 UNP P00178 ALA 26 ENGINEERED MUTATION SEQADV 3TMZ LYS A 27 UNP P00178 HIS 27 ENGINEERED MUTATION SEQADV 3TMZ LYS A 29 UNP P00178 ARG 29 ENGINEERED MUTATION SEQADV 3TMZ SER A 221 UNP P00178 PRO 221 SEE REMARK 999 SEQADV 3TMZ TYR A 226 UNP P00178 HIS 226 ENGINEERED MUTATION SEQADV 3TMZ HIS A 492 UNP P00178 EXPRESSION TAG SEQADV 3TMZ HIS A 493 UNP P00178 EXPRESSION TAG SEQADV 3TMZ HIS A 494 UNP P00178 EXPRESSION TAG SEQADV 3TMZ HIS A 495 UNP P00178 EXPRESSION TAG SEQRES 1 A 476 MET ALA LYS LYS THR SER SER LYS GLY LYS LEU PRO PRO SEQRES 2 A 476 GLY PRO SER PRO LEU PRO VAL LEU GLY ASN LEU LEU GLN SEQRES 3 A 476 MET ASP ARG LYS GLY LEU LEU ARG SER PHE LEU ARG LEU SEQRES 4 A 476 ARG GLU LYS TYR GLY ASP VAL PHE THR VAL TYR LEU GLY SEQRES 5 A 476 SER ARG PRO VAL VAL VAL LEU CYS GLY THR ASP ALA ILE SEQRES 6 A 476 ARG GLU ALA LEU VAL ASP GLN ALA GLU ALA PHE SER GLY SEQRES 7 A 476 ARG GLY LYS ILE ALA VAL VAL ASP PRO ILE PHE GLN GLY SEQRES 8 A 476 TYR GLY VAL ILE PHE ALA ASN GLY GLU ARG TRP ARG ALA SEQRES 9 A 476 LEU ARG ARG PHE SER LEU ALA THR MET ARG ASP PHE GLY SEQRES 10 A 476 MET GLY LYS ARG SER VAL GLU GLU ARG ILE GLN GLU GLU SEQRES 11 A 476 ALA ARG CYS LEU VAL GLU GLU LEU ARG LYS SER LYS GLY SEQRES 12 A 476 ALA LEU LEU ASP ASN THR LEU LEU PHE HIS SER ILE THR SEQRES 13 A 476 SER ASN ILE ILE CYS SER ILE VAL PHE GLY LYS ARG PHE SEQRES 14 A 476 ASP TYR LYS ASP PRO VAL PHE LEU ARG LEU LEU ASP LEU SEQRES 15 A 476 PHE PHE GLN SER PHE SER LEU ILE SER SER PHE SER SER SEQRES 16 A 476 GLN VAL PHE GLU LEU PHE SER GLY PHE LEU LYS TYR PHE SEQRES 17 A 476 PRO GLY THR HIS ARG GLN ILE TYR ARG ASN LEU GLN GLU SEQRES 18 A 476 ILE ASN THR PHE ILE GLY GLN SER VAL GLU LYS HIS ARG SEQRES 19 A 476 ALA THR LEU ASP PRO SER ASN PRO ARG ASP PHE ILE ASP SEQRES 20 A 476 VAL TYR LEU LEU ARG MET GLU LYS ASP LYS SER ASP PRO SEQRES 21 A 476 SER SER GLU PHE HIS HIS GLN ASN LEU ILE LEU THR VAL SEQRES 22 A 476 LEU SER LEU PHE PHE ALA GLY THR GLU THR THR SER THR SEQRES 23 A 476 THR LEU ARG TYR GLY PHE LEU LEU MET LEU LYS TYR PRO SEQRES 24 A 476 HIS VAL THR GLU ARG VAL GLN LYS GLU ILE GLU GLN VAL SEQRES 25 A 476 ILE GLY SER HIS ARG PRO PRO ALA LEU ASP ASP ARG ALA SEQRES 26 A 476 LYS MET PRO TYR THR ASP ALA VAL ILE HIS GLU ILE GLN SEQRES 27 A 476 ARG LEU GLY ASP LEU ILE PRO PHE GLY VAL PRO HIS THR SEQRES 28 A 476 VAL THR LYS ASP THR GLN PHE ARG GLY TYR VAL ILE PRO SEQRES 29 A 476 LYS ASN THR GLU VAL PHE PRO VAL LEU SER SER ALA LEU SEQRES 30 A 476 HIS ASP PRO ARG TYR PHE GLU THR PRO ASN THR PHE ASN SEQRES 31 A 476 PRO GLY HIS PHE LEU ASP ALA ASN GLY ALA LEU LYS ARG SEQRES 32 A 476 ASN GLU GLY PHE MET PRO PHE SER LEU GLY LYS ARG ILE SEQRES 33 A 476 CYS LEU GLY GLU GLY ILE ALA ARG THR GLU LEU PHE LEU SEQRES 34 A 476 PHE PHE THR THR ILE LEU GLN ASN PHE SER ILE ALA SER SEQRES 35 A 476 PRO VAL PRO PRO GLU ASP ILE ASP LEU THR PRO ARG GLU SEQRES 36 A 476 SER GLY VAL GLY ASN VAL PRO PRO SER TYR GLN ILE ARG SEQRES 37 A 476 PHE LEU ALA ARG HIS HIS HIS HIS HET HEM A 501 43 HET CM5 A 502 34 HET 06X A 503 56 HET 06X A 504 28 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM CM5 5-CYCLOHEXYL-1-PENTYL-BETA-D-MALTOSIDE HETNAM 06X AMLODIPINE HETSYN HEM HEME HETSYN CM5 5-CYCLOHEXYLPENTYL 4-O-ALPHA-D-GLUCOPYRANOSYL-BETA-D- HETSYN 2 CM5 GLUCOPYRANOSIDE; CYMAL-5 HETSYN 06X O3-ETHYL O5-METHYL 2-(2-AZANYLETHOXYMETHYL)-4-(2- HETSYN 2 06X CHLOROPHENYL)-6-METHYL-1,4-DIHYDROPYRIDINE-3,5- HETSYN 3 06X DICARBOXYLATE FORMUL 2 HEM C34 H32 FE N4 O4 FORMUL 3 CM5 C23 H42 O11 FORMUL 4 06X 2(C20 H25 CL N2 O5) FORMUL 6 HOH *203(H2 O) HELIX 1 1 ASN A 42 MET A 46 5 5 HELIX 2 2 GLY A 50 GLY A 63 1 14 HELIX 3 3 CYS A 79 VAL A 89 1 11 HELIX 4 4 ALA A 92 SER A 96 5 5 HELIX 5 5 VAL A 104 GLN A 109 1 6 HELIX 6 6 GLY A 112 ALA A 116 5 5 HELIX 7 7 ASN A 117 ARG A 133 1 17 HELIX 8 8 SER A 141 SER A 160 1 20 HELIX 9 9 ASN A 167 PHE A 184 1 18 HELIX 10 10 ASP A 192 SER A 210 1 19 HELIX 11 11 SER A 211 LYS A 225 1 15 HELIX 12 12 GLY A 229 THR A 255 1 27 HELIX 13 13 ASP A 263 ASP A 275 1 13 HELIX 14 14 LYS A 276 ASP A 278 5 3 HELIX 15 15 HIS A 284 THR A 300 1 17 HELIX 16 16 THR A 300 TYR A 317 1 18 HELIX 17 17 TYR A 317 ILE A 332 1 16 HELIX 18 18 ALA A 339 LYS A 345 5 7 HELIX 19 19 MET A 346 ASP A 361 1 16 HELIX 20 20 VAL A 391 HIS A 397 1 7 HELIX 21 21 ASN A 409 LEU A 414 5 6 HELIX 22 22 LEU A 431 ILE A 435 5 5 HELIX 23 23 GLY A 438 ASN A 456 1 19 HELIX 24 24 PRO A 464 ILE A 468 5 5 SHEET 1 A 5 VAL A 65 TYR A 69 0 SHEET 2 A 5 PRO A 74 LEU A 78 -1 O VAL A 77 N PHE A 66 SHEET 3 A 5 GLU A 387 PRO A 390 1 O GLU A 387 N VAL A 76 SHEET 4 A 5 HIS A 369 THR A 370 -1 N HIS A 369 O VAL A 388 SHEET 5 A 5 GLY A 97 ARG A 98 -1 N GLY A 97 O THR A 370 SHEET 1 B 2 THR A 375 PHE A 377 0 SHEET 2 B 2 TYR A 380 ILE A 382 -1 O ILE A 382 N THR A 375 SHEET 1 C 2 PHE A 457 ALA A 460 0 SHEET 2 C 2 ARG A 487 ALA A 490 -1 O LEU A 489 N SER A 458 LINK SG CYS A 436 FE HEM A 501 1555 1555 2.38 LINK FE HEM A 501 NADB06X A 503 1555 1555 2.05 LINK FE HEM A 501 NADA06X A 503 1555 1555 2.13 CISPEP 1 MET A 137 GLY A 138 0 10.73 SITE 1 AC1 21 ARG A 98 VAL A 113 ILE A 114 TRP A 121 SITE 2 AC1 21 ARG A 125 ALA A 298 GLY A 299 THR A 302 SITE 3 AC1 21 THR A 303 THR A 306 VAL A 367 HIS A 369 SITE 4 AC1 21 PRO A 428 PHE A 429 SER A 430 ARG A 434 SITE 5 AC1 21 CYS A 436 LEU A 437 GLY A 438 06X A 503 SITE 6 AC1 21 HOH A 684 SITE 1 AC2 11 PHE A 184 LYS A 186 PHE A 188 VAL A 194 SITE 2 AC2 11 PHE A 195 PHE A 244 LYS A 251 HOH A 631 SITE 3 AC2 11 HOH A 638 HOH A 734 HOH A 770 SITE 1 AC3 15 ILE A 101 ILE A 114 PHE A 115 PHE A 206 SITE 2 AC3 15 ILE A 209 PHE A 297 ALA A 298 GLU A 301 SITE 3 AC3 15 THR A 302 VAL A 367 VAL A 477 HEM A 501 SITE 4 AC3 15 06X A 504 HOH A 705 HOH A 790 SITE 1 AC4 12 LEU A 51 LEU A 70 ILE A 101 ILE A 209 SITE 2 AC4 12 GLN A 215 GLU A 218 PHE A 365 GLU A 387 SITE 3 AC4 12 VAL A 477 06X A 503 HOH A 794 HOH A 795 CRYST1 92.995 92.995 152.773 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010753 0.006208 0.000000 0.00000 SCALE2 0.000000 0.012417 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006546 0.00000